Form 8-K - Current report:
SEC Accession No. 0001087294-13-000004
Filing Date
2013-06-03
Accepted
2013-06-03 17:08:03
Documents
2
Period of Report
2013-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kcpixandcardinalagreement.htm 8-K 26738
2 EXHIBIT 10.7.1 exhibit1071amendmenttoexcl.htm EX-10.7.1 144201
  Complete submission text file 0001087294-13-000004.txt   172025
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13888676
SIC: 2834 Pharmaceutical Preparations